Heartflow (HTFL) Return on Capital Employed (2025)

Heartflow (HTFL) recorded quarterly Return on Capital Employed of 5.66% in Q4 2025, up 168.19% quarter-over-quarter from 8.31% in Q3 2025.

Heartflow (HTFL) Return on Capital Employed (2025) Analysis & Trends

Heartflow's Return on Capital Employed history runs 1 years deep, the most recent figure standing at 5.66% for Q4 2025.

In Q4 2025, Return on Capital Employed changed N/A year-over-year to 5.66%; the TTM figure through Dec 2025 stood at 5.66% (changed N/A YoY), while the FY2025 annual figure was 12.48%, changed N/A from the prior year.
Return on Capital Employed was 5.66% for Q4 2025 at Heartflow, up from 8.31% in the prior quarter.
In the past five years, Return on Capital Employed ranged from a high of 5.66% in Q4 2025 to a low of 16.67% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	13.00%
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	2.09%
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	10.67%
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-163.65%
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-4.23%
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	21.81%
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	4.73%
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	4.60%
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	2.23%
10	Heartflow	1.24 Bn	1.06 Bn	39.06 Mn	5.66%

Download Data